ArcherDX is now Invitae, bringing the future of precision oncology to cancer care. The transaction was completed in October 2020. Learn more here.
Precision oncology
in your lab
ArcherDX is now Invitae. The combination was completed in October 2020 to bring comprehensive cancer genetics and precision oncology to patients worldwide.
The global fight against cancer requires advanced molecular detection products that are accurate, actionable, easy-to-use and available worldwide.
